Rosh Dias
Chief Tech/Sci/R&D Officer presso COHERUS BIOSCIENCES, INC.
Profilo
Rosh Dias currently works at The Royal College of Physicians, as Member and Coherus BioSciences, Inc., as Chief Medical Officer from 2022.
Mr. Dias also formerly worked at Aventis Pharmaceuticals, Inc., as Global Medical Director-Oncology, Amgen, Inc., as Vice President-Global Scientific Affairs from 2015 to 2018, Onyx Pharmaceuticals, Inc., as VP, Head-Global Medical & Scientific Affairs from 2014 to 2015, Novartis International AG, as Vice President-Oncology Scientific Operations from 2004 to 2014, Indivior PLC, as Chief Medical Officer from 2019 to 2020, Novartis Australia Pty Ltd., as Head-Clinical Development & Medical Affairs from 2004 to 2014, and Spruce Biosciences, Inc., as Chief Medical Officer.
Mr. Dias received his graduate degree from The Royal College of Physicians and graduate degree from Charing Cross Hospital Medical School.
Posizioni attive di Rosh Dias
| Società | Posizione | Inizio |
|---|---|---|
| COHERUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 15/03/2022 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Precedenti posizioni note di Rosh Dias
| Società | Posizione | Fine |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 14/03/2022 |
| INDIVIOR PLC | Chief Tech/Sci/R&D Officer | 01/08/2020 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/01/2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Chief Tech/Sci/R&D Officer | 01/03/2015 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2014 |
Formazione di Rosh Dias
| The Royal College of Physicians | Graduate Degree |
| Charing Cross Hospital Medical School | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| INDIVIOR PLC | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Health Technology |
- Borsa valori
- Insiders
- Rosh Dias
